Cardiovascular Outcomes in Persons With HIV and Heart Failure: Medication Class or Suboptimal Viral Suppression?

Robert S. Rosenson, Rupert Kaul

Research output: Contribution to journalEditorial

1 Scopus citations
Original languageEnglish
Pages (from-to)531-533
Number of pages3
JournalJournal of the American College of Cardiology
Issue number5
StatePublished - 31 Jul 2018


  • HIV
  • cardiomyopathy
  • cardiovascular mortality
  • inflammation
  • protease inhibitors
  • viremia

Cite this